1613-4133/asset/olbannerleft.jpg?v=1&s=adbeac83cec434321969eead140804a1d765a561)
Research Article
Epigallocatechin gallate (EGCG) attenuates high glucose-induced insulin signaling blockade in human hepG2 hepatoma cells
Article first published online: 21 MAY 2008
DOI: 10.1002/mnfr.200700437
Copyright © 2008 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Issue
Molecular Nutrition & Food Research
Special Issue: Nutrition and Inflammatory Bowel Disease
Volume 52, Issue 8, pages 930–939, August 2008
Additional Information
How to Cite
Lin, C.-L. and Lin, J.-K. (2008), Epigallocatechin gallate (EGCG) attenuates high glucose-induced insulin signaling blockade in human hepG2 hepatoma cells. Mol. Nutr. Food Res., 52: 930–939. doi: 10.1002/mnfr.200700437
Publication History
- Issue published online: 18 AUG 2008
- Article first published online: 21 MAY 2008
- Manuscript Revised: 20 DEC 2007
- Manuscript Received: 23 OCT 2007
Funded by
- National Science Council, Taiwan. Grant Number: NSC-96-2311-B002-020, NSC-96-2311-B002-026
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via Athens http://onlinelibrary.wiley.com/athens or other institutional login options http://onlinelibrary.wiley.com/login-options .
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!